Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Strohmaier

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Royal Society Open Science|September 27, 2021
Quota-based debiasing can decrease representation of the most under-represented groupsI Smirnov, F Lemmerich, M Strohmaier
Cell Cycle (Georgetown, Tex.)|November 14, 2002
Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle controlCharles H Spruck, Heimo M Strohmaier
Annual Review of Medicine|October 31, 2007
Advances in antifungal therapyCarole A Sable, Kim M Strohmaier, Jeffrey A Chodakewitz
Journal of Glaucoma|November 19, 2009
Comparison of quality of life and patient preference of dorzolamide and pilocarpine as adjunctive therapy to timolol in the treatment of glaucomaR Laibovitz, E R Strahlman, B L Barber, et al.
International Journal of Antimicrobial Agents|September 20, 2011
Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief reportAngela L Ngai, Michael R Bourque, Robert J Lupinacci, et al.
Journal of Critical Care|September 18, 2007
Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trialMark J DiNubile, Robert J Lupinacci, Kim M Strohmaier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 8, 2008
Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infectionsM J Dinubile, K M Strohmaier, R J Lupinacci, et al.
Antimicrobial Agents and Chemotherapy|March 17, 2010
Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin databaseArnaldo L Colombo, Angela L Ngai, Michael Bourque, et al.
AIDS (London, England)|April 28, 2011
Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studiesJürgen K Rockstroh, Hedy Teppler, Jing Zhao, et al.
Gastroenterology|January 24, 2007
Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNAKatrin Panzitt, Marisa M O Tschernatsch, Christian Guelly, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Royal Society Open Science|September 27, 2021
Quota-based debiasing can decrease representation of the most under-represented groupsI Smirnov, F Lemmerich, M Strohmaier
Cell Cycle (Georgetown, Tex.)|November 14, 2002
Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle controlCharles H Spruck, Heimo M Strohmaier
Annual Review of Medicine|October 31, 2007
Advances in antifungal therapyCarole A Sable, Kim M Strohmaier, Jeffrey A Chodakewitz
Journal of Glaucoma|November 19, 2009
Comparison of quality of life and patient preference of dorzolamide and pilocarpine as adjunctive therapy to timolol in the treatment of glaucomaR Laibovitz, E R Strahlman, B L Barber, et al.
International Journal of Antimicrobial Agents|September 20, 2011
Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief reportAngela L Ngai, Michael R Bourque, Robert J Lupinacci, et al.
Journal of Critical Care|September 18, 2007
Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trialMark J DiNubile, Robert J Lupinacci, Kim M Strohmaier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 8, 2008
Efficacy and safety of caspofungin therapy in elderly patients with proven or suspected invasive fungal infectionsM J Dinubile, K M Strohmaier, R J Lupinacci, et al.
Antimicrobial Agents and Chemotherapy|March 17, 2010
Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin databaseArnaldo L Colombo, Angela L Ngai, Michael Bourque, et al.
AIDS (London, England)|April 28, 2011
Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studiesJürgen K Rockstroh, Hedy Teppler, Jing Zhao, et al.
Gastroenterology|January 24, 2007
Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNAKatrin Panzitt, Marisa M O Tschernatsch, Christian Guelly, et al.
Pageof 3